About Index Trending news
Lists
Pricing
Amgen Inc.

Amgen Inc.

Amgen Inc.

Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

30 Oct 2017
$30,000,000
Venture capital (Series A)
07 Sep 2017
$240,000,000
Venture capital (Series B)

WuXi NextCODE racks up $240 mln Series B

PE Hub
+1
23 Aug 2017
$6,000,000
Venture capital (Series C)

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

Xconomy
+1
25 Apr 2017
$29,000,000
Venture capital (Series C)

GV joins $29 million investment into Science 37 to bring clinical trials to the home

VentureBeat
+1
06 Jan 2017

Amgen Partners with SiteOne to Develop Pain Treatments Genetic Engineering & Biotechnology News - Biotech from Bench to Business

GEN
+1
20 Jul 2016
$11,900,000
Venture capital (Series B)

Amgen and Merck KGaA Invest in Bostons Akili Increasing Funding Round to 42 4 Million

biospace
+1
18 Feb 2015
31 Aug 2011
$30,000,000
Venture capital (Series B)
17 Nov 2010
$36,500,000
Venture capital (Series C)
03 Jun 2009
$4,000,000
Venture capital (Series B)
Boulder Ventures, Broadview Ventures, The Peierls Foundation, +1
09 May 2006
$43,800,000
Venture capital (Series C)